TMO — Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Company profile
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
- Exchange: NYSE
- Employees: 125,000
- Website: https://www.thermofisher.com
Latest SEC filings for TMO
- 11-K — 2026-06-23
- 8-K — 2026-05-26
- 10-Q — 2026-05-01
- 8-K — 2026-04-23
- ARS — 2026-04-07
- 8-K — 2026-03-24
- 10-K — 2026-02-26
- 8-K — 2026-02-12
- 424B5 — 2026-02-10
- 144 — 2026-02-09
Latest TMO news
- — Company News for Oct 22, 2026 (Zacks Investment Research)
- — Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors (The Motley Fool)
- — Thermo Fisher posts Q3 beat as lab products unit outperforms (seekingalpha_market)
- — Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates (Zacks Investment Research)
- — Thermo Fisher Scientific Non-GAAP EPS of $6.68 beats by $0.28, revenue of $12.14B beats by $190M (seekingalpha_market)
- — Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again (Zacks Investment Research)
- — Forge’s Fierce Life Sciences Announces 2026 Fierce Innovation Awards Finalists and Unveils the Fierce Vanguard Gala (GlobeNewswire Inc.)
- — Clinical Trial Supplies Market Forecasts Growth from $5.7 Billion (2025) to $10.7 Billion by 2033, Profiling Thermo Fisher Scientific, Catalent, Almac Group, UPS Healthcare & 6 Other Key Players (GlobeNewswire Inc.)
- — Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsight (GlobeNewswire Inc.)
- — Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth (zacks.com)
Educational tool only — not investment advice.